CAN
PACB icon

Cetera Advisor Networks’s Pacific Biosciences PACB Stock Holding History

Cetera Advisor Networks’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-11,815
Closed -$98.7K – 2846
2023
Q3 		$98.7K Sell
11,815
-398
-3% -$4.55K ﹤0.01% 2570
2023
Q2 		$162K Buy
+12,213
New +$148K ﹤0.01% 2392

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.39B AUM 10.34% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Cetera Advisor Networks's PACB Position: Q4 2023 in Review

Cetera Advisor Networks sold out of Pacific Biosciences (PACB) in Q4 2023, closing a stake of 11,815 shares — an estimated $98.7K sold.

Cetera Advisor Networks first reported a position in PACB in Q2 2023 and held it in 2 quarters. The position peaked at $162K in Q2 2023. 274 funds tracked by Wall St. Rank hold PACB as of Q4 2023.

  • Cetera Advisor Networks reported no remaining Pacific Biosciences position as of Q4 2023 after selling out during the quarter.
  • Cetera Advisor Networks sold 11,815 Pacific Biosciences shares in Q4 2023, an estimated $98.7K.
  • Cetera Advisor Networks first reported a position in Pacific Biosciences in Q2 2023 and held it in 2 quarters.
  • Cetera Advisor Networks's Pacific Biosciences position peaked at $162K in Q2 2023.
  • 274 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2023.

Based on Cetera Advisor Networks's 13F filing for Q4 2023, filed 13 Feb 2024.